Exelixis Inc at Bank of America Merrill Lynch Napa Healthcare Conference (Virtual) Transcript
Good day, everybody. My name is Jason Gerberry. I cover specialty pharma and smid-cap biotech at Bank of America. I'm pleased to be introducing our next company presenter, Exelixis, and CEO, Mike Morrissey. Mike, we've done Vegas and Napa now digitally. We're very -- very sterile, very benign, anti-climactic. But glad to have you nonetheless.
Well, I'm in my same living room with my same clothes on and my same tennis shoes. So yes, Groundhog Day all over again. But it's great to be here, and thanks again for the invite.
And again, before we begin, I'll just remind everybody that I'll be making forward-looking statements today. So please see our SEC filings for a description of the risks that we face in our business.
Yes. Okay. Great. So look, for everybody
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
